Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HealthSpan

Showing results (261-270 of 487) with videos related to

Pageof 49
Sort By:
Healthspan|April 9, 1991
Health insurance industry shouldn't be exempt from antitrust lawsL G Goldberg, W Greenberg
Healthspan|February 7, 1993
New pharmacy mandates and practice standards now taking effect under OBRA '90 deadlineF H Fern
Healthspan|May 8, 1993
The home infusion industry: patients' angel or their ruthless plunderer?R E Margolis
Healthspan|June 7, 1992
Is FDA's medical device evaluation process overly complaisant to industry?R E Margolis
Healthspan|June 7, 1992
The National Practitioner Data Bank: big brother or paper tiger?M A Kadzielski
Healthspan|August 6, 1992
The 1992 biotechnology agenda: a message for candidates Bush and ClintonS A Duzan
Healthspan|August 6, 1992
Genetic discrimination by insurers: legal protections needed from abuse of biotechnologyT E Morelli
Healthspan|December 9, 1993
Why health care parties should mediate rather than litigateW A Quinby
Healthspan|February 7, 1994
Medical savings accounts cut corporate health costs, promote employee wellnessJ P Rooney
Healthspan|February 7, 1994
Clinton health reform plan sinking: will Stark reform plan replace it?R E Margolis
Pageof 49

Showing results (261-270 of 487) with videos related to

Sort By:
Pageof 49
Healthspan|April 9, 1991
Health insurance industry shouldn't be exempt from antitrust lawsL G Goldberg, W Greenberg
Healthspan|February 7, 1993
New pharmacy mandates and practice standards now taking effect under OBRA '90 deadlineF H Fern
Healthspan|May 8, 1993
The home infusion industry: patients' angel or their ruthless plunderer?R E Margolis
Healthspan|June 7, 1992
Is FDA's medical device evaluation process overly complaisant to industry?R E Margolis
Healthspan|June 7, 1992
The National Practitioner Data Bank: big brother or paper tiger?M A Kadzielski
Healthspan|August 6, 1992
The 1992 biotechnology agenda: a message for candidates Bush and ClintonS A Duzan
Healthspan|August 6, 1992
Genetic discrimination by insurers: legal protections needed from abuse of biotechnologyT E Morelli
Healthspan|December 9, 1993
Why health care parties should mediate rather than litigateW A Quinby
Healthspan|February 7, 1994
Medical savings accounts cut corporate health costs, promote employee wellnessJ P Rooney
Healthspan|February 7, 1994
Clinton health reform plan sinking: will Stark reform plan replace it?R E Margolis
Pageof 49